Is there a Role for Immunotherapy in Treatment of Cervical Cancer?

Cervical cancer is the fourth most commonly diagnosed and one of the deadliest cancers in women worldwide. There is an urgent need for more active treatments and rationally designed targeted therapies for advanced disease. Recently, immunotherapy has been proven to be effective in several solid tumors. There are few phase I/II studies in advanced or recurrent cervical cancer patients, no quality of life analysis in the studies, limited objective responses, and no clear superiority over second-line chemotherapy, but certainly more expense. Therefore, currently there is no role of immunotherapy in treatment of cervical cancer.